Cognitive behavioral therapy for psychological distress in young people diagnosed with cancer during adolescence

ISRCTN ISRCTN15975376
DOI https://doi.org/10.1186/ISRCTN15975376
Secondary identifying numbers U-CARE: MAYA
Submission date
07/08/2017
Registration date
22/08/2017
Last edited
21/09/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Young people who are diagnosed with cancer during adolescence may suffer from psychological distress after the end of cancer treatment. Cognitive behavior therapy (CBT) is a talking therapy that is effective for a range of psychological disorders and has been tested for the treatment of depression, anxiety and post-traumatic stress disorder. There are currently few psychological treatments developed specifically to fit the needs of young survivors of cancer and no study has tested individualized CBT specifically tailored to reduce psychological distress in young survivors of cancer diagnosed during adolescence. The aim of this study is therefore to develop and test a CBT-based treatment targeting cancer-related psychological distress experienced by young people who have completed treatment for cancer diagnosed during adolescence.

Who can participate?
Young people aged between 15-25 who have been diagnosed with cancer during adolescence, have completed successful cancer treatment and experience cancer-related suffering

What does the study involve?
Participants are offered up to 15 weekly 45-minute sessions of individual CBT provided by three resident psychologists. Psychological distress is assessed before treatment, at the end of treatment, and at 3 months after the end of treatment.

What are the possible benefits and risks of participating?
By enrolling in this study participants can receive psychological support. There are no anticipated side effects of the treatment. Working with one's mental health problems can involve some distress. Participants who do not experience improvement or who deteriorate during the treatment might have less confidence in psychological treatments in the future. Participants in need of immediate/more intensive/other psychological treatment than can be offered within this study are guided to appropriate healthcare.

Where is the study run from?
Uppsala University Children's Hospital (Sweden)

When is the study starting and how long is it expected to run for?
May 2014 to October 2016

Who is funding the study?
1. Swedish Research Council
2. Swedish Childhood Cancer Foundation
3. Swedish Cancer Society

Who is the main contact?
Prof. Louise von Essen
louise-von.essen@kbh.uu.se

Contact information

Prof Louise von Essen
Scientific

Uppsala universitet
Uppsala biomedicinska centrum
Institutionen för kvinnors- och barns hälsa
Klinisk psykologi i hälso- och sjukvård
Box 572
Uppsala
75123
Sweden

ORCiD logoORCID ID 0000-0001-5816-7231
Phone +46 (0)184 713 484
Email louise-von.essen@kbh.uu.se

Study information

Study designSingle-group non-randomised open trial
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleDevelopment of psychological treatment for cancer-related suffering experienced by young people diagnosed with cancer during adolescence
Study objectivesSince there are no evidence-based interventions for young survivors of cancer during adolescence who experience cancer-related suffering, the purpose of the current study was to develop and preliminary evaluate if individual CBT can reduce distress among these survivors.
Ethics approval(s)Regional Ethical Review Board in Uppsala, Sweden, 22/12/2014, Dnr: 2014/443
Health condition(s) or problem(s) studiedCancer-related psychological distress
InterventionAll participants are offered up to 15 weekly 45-minute sessions of individual CBT provided by three resident psychologists under supervision. The CBT interventions are based on a clinical behavior analysis. Psychological distress is assessed before treatment (baseline), at the end of treatment (post-treatment), and 3-months after end of treatment.
Intervention typeBehavioural
Primary outcome measure1. Anxiety, assessed with the Beck Anxiety Inventory (BAI) at baseline, post-treatment and at 3 months after end of treatment
2. Depression, assessed with the Montgomery Åsberg Depression Rating Scale Self-assessment (MADRS-S) at baseline, post-treatment and at 3 months after end of treatment
3. Post-traumatic stress symptoms, assessed with the The PTSD Checklist - Civilian (PCL-C) at baseline, post-treatment and at 3 months after end of treatment
4. Worry, assessed with the Penn State Worry Questionnaire (PSWQ) at baseline, post-treatment and at 3 months after end of treatment
Secondary outcome measures1. Body dissatisfaction, assessed with the Body Image Scale (BIS) at baseline, post-treatment and at 3 months after end of treatment
2. Experiential avoidance, assessed with the Acceptance and Action Questionnaire (AAQ-II) at baseline, post-treatment and at 3 months after end of treatment
3. Fatigue, assessed with the Fatigue Assessment Scale (FAS) at baseline, post-treatment and at 3 months after end of treatment
4. Functional impairment, assessed with the Sheehan Disability Scale (SDS) at baseline, post-treatment and at 3 months after end of treatment
5. Health anxiety, assessed with the Short Health Anxiety Inventory (SHAI) at baseline, post-treatment and at 3 months after end of treatment
6. Somatic symptoms, assessed with the Patient Health Questionnaire-15 (PHQ-15) at baseline, post-treatment and at 3 months after end of treatment
7. Rumination, assessed with the Rumination Scale of the Response Style Questionnaire (RSQ): at baseline, post-treatment and at 3 months after end of treatment
8. The presence of psychiatric disorders, assessed with the Mini-International Neuropsychiatric Interview (M.I.N.I), a structured diagnostic psychiatric interview for DSM-IV and ICD-10, at baseline, post-treatment and at 3 months after end of treatment
Overall study start date01/05/2014
Completion date10/10/2016

Eligibility

Participant type(s)Patient
Age groupMixed
SexBoth
Target number of participants20
Key inclusion criteria1. Aged 15-25 years at study start
2. Diagnosed with cancer when aged 13-18 years
3. Treated at a paediatric oncology unit in Sweden
4. Completed successful cancer treatment
5. Experience cancer-related suffering
Key exclusion criteria1. Currently receive psychological treatment
2. Display psychiatric symptoms in immediate need of treatment
Date of first enrolment27/02/2015
Date of final enrolment03/11/2015

Locations

Countries of recruitment

  • Sweden

Study participating centre

Uppsala University Children's Hospital
Akademiska barnsjukhuset, ing. 95 nbv
Uppsala
75185
Sweden

Sponsor information

Uppsala University
University/education

Box 256
Uppsala
75105
Sweden

Website www.uu.se
ROR logo "ROR" https://ror.org/048a87296

Funders

Funder type

Government

Vetenskapsrådet
Government organisation / National government
Alternative name(s)
Swedish Research Council, VR
Location
Sweden
Barncancerfonden
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Swedish Childhood Cancer Foundation
Location
Sweden
Cancerfonden
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Swedish Cancer Society
Location
Sweden

Results and Publications

Intention to publish date01/11/2017
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planThe results from the trial will be published in a doctoral dissertation at Uppsala University and will be submitted for publication in a scientific journal approximately in November 2017.
IPD sharing planEthical restrictions prohibit making the dataset publicly available. Data are available on request from the research group Clinical Psychology in Healthcare at the Department of Women's and Children's Health, Uppsala University for researchers who meet the criteria for access to confidential data. Requests should be sent to PI Prof. Louise von Essen (louise-von.essen@kbh.uu.se).

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Other publications Qualitative feasibility results 17/04/2018 21/09/2023 Yes No
Protocol file 21/09/2023 No No

Additional files

ISRCTN15975376_Protocol.pdf

Editorial Notes

21/09/2023: Publication reference and protocol (not peer reviewed) added.
24/05/2019: Internal review.